Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA staurosporine CTRPv2 pan-cancer AAC -0.03 0.7
mRNA KH-CB19 CTRPv2 pan-cancer AAC 0.019 0.7
mRNA etoposide CTRPv2 pan-cancer AAC -0.012 0.7
mRNA brivanib CTRPv2 pan-cancer AAC -0.014 0.7
mRNA IU1 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.015 0.7
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.019 0.7
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
Download CSV